People · Operator
Named in public records as an officer, director or promoter · active 2023–2026 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NurExone Biologic Inc. | — | Biotechnology | Seed | $5.8M | $532K | 2023 |
Eran Ovadya at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eran Ovadya on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Yoram Drucker | 1 | 6 |
| James Richardson | 1 | 4 |
| Lior Shaltiel | 1 | 1 |
| Eyal Gabbai | 1 | 1 |
| Oded Orgil | 1 | 1 |
| Gadi Riesenfeld | 1 | 1 |
| Oded 40 Orgil | 1 | 1 |
| James 40 Richardson | 1 | 1 |
| Yoram 40 Drucker | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.